Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The aim of this study was to evaluate the efficacy of the association of intralesional verapamil (ILV) injection with oral antioxidants compared with ILV monotherapy in patients with early onset of Peyronie's disease (PD) at 12-week follow-up. Group A (n = 52) received ILV 10 mg weekly for 12 weeks, while group B (n = 53) received ILV 10 mg weekly for 12 weeks + antioxidants orally one tablet once a day for 3 months. The main efficacy outcomes were the change in plaque size (PS), penile curvature (PC), visual analogue score (VAS), IIEF-15 and IIEF-15 subdomains. Both groups showed significant improvement from baseline to week 12 relative to PS and PC, while group B also in IIEF-15 score (mean difference: 5.51, P < 0.01) and VAS (mean difference: -2.71, P < 0.01). No significant differences were observed between both groups in PS and PC. Finally, both groups showed significant increase in orgasmic function (IIEF-OF) and overall satisfaction (IIEF-OS), while group B showed significant improvement also in intercourse satisfaction (IIEF-IS). Significant differences were found relative to IIEF-OF, IIEF-IS, IIEF-OS and VAS scores in the group B compared with group A. Patients affected by PD may benefit from combination treatment with ILV and oral antioxidants thanks to the improvement in IIEF-OF, IIEF-IS and IIEF-OS at 12 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EAU guidelines on penile curvature
Hatzimouratidis, K., Eardley, I., Giuliano, F., Hatzichristou, D., Moncada, I., Salonia, A., Vardi, Y., & Wespes, E. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.040 · Cited by 309 · cited 2×
“…factors have been associated with PD such as history of genital and perineal injuries, diabetes mellitus, lipid abnormalities, hypertension, Dupuytren’s contracture, smoking and alcohol consumption (Kadioglu et al., 2002; Sommer et al., 2002; Hatzimouratidis et al., 2012; Garaffa et al., 2013).”
BackgroundEl-Sakka, A. I., Hassoba, H. M., Pillarisetty, R. J., Dahiya, R., & Lue, T. F. (1997) · Journal of Urology · doi:10.1016/s0022-5347(01)64223-x · Cited by 250 · cited 2×
“Consequently, the inflammatory response determine an unregulated extracellular matrix deposition including fibronectin and collagen, and ultimately plaque formation, which does not appear to undergo proper scar remodelling, leaving an inelastic segment in the involved tunica albuginea (El-Sakka et al., 1997).”
BackgroundPeyronie’s Disease Intervention Trials: Methodological Challenges and Issues
Müller, A., & Mulhall, J. P. (2009) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2008.01081.x · Cited by 80 · cited 1×
“This fact is due to several methodological problems including uncontrolled studies, limited number of patients treated, short-term follow-up and different outcome measures (Muller & Mulhall, 2009; Favilla et al., 2010).”
BackgroundPaulis, G., & Brancato, T. (2012) · Inflammation & Allergy - Drug Targets · doi:10.2174/187152812798889321 · Cited by 60 · cited 1×
“Moreover, propolis, blueberry, Muira puama, Damiana and Soja have been found to inhibit NF-KB activity, the expression of COX-2 and the production of interleukins through their derivative flavonoid compounds (Loreto et al., 2011; Paulis & Brancato, 2012).”
BackgroundA brief historical survey of “Peyronie’s disease.”
Musitelli, S., Bossi, M., & Jallous, H. (2008) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2007.00692.x · Cited by 43 · cited 1×
“The aetiology of PD is still unknown; however, an insult (repetitive microvascular injury or trauma) to the tunica albuginea is the widely stated hypothesis on the aetiology of the disease (Musitelli et al., 2008).”
Background
Cited by
Evidence-Based Management Guidelines on Peyronie's Disease
Chung, E., Ralph, D., Kagioglu, A., Garaffa, G., Shamsodini, A., Bivalacqua, T., Glina, S., Hakim, L., Sadeghi-Nejad, H., & Broderick, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2016.04.062 · Cited by 227
Paulis, G., Romano, G., Paulis, L., & Barletta, D. (2017) · Advances in Urology · doi:10.1155/2017/4653512 · Cited by 44
“97), statistically significant results were obtained in group B in regard to orgasmic function (subdomain of 15-question International Index of Erectile Function, IIEF), intercourse satisfaction (subdomain of IIEF), overall satisfaction (subdomain of IIEF), and pain/visual analogue score (VAS) [61].”
BackgroundMethodInfluentialCocci, A., Di Maida, F., Cito, G., Verrienti, P., Laruccia, N., Campi, R., Mari, A., Di Mauro, M., Falcone, M., Cacciamani, G. E., et al. (2021) · The World Journal of Men's Health · doi:10.5534/wjmh.190108 · Cited by 30
Self-citationPeyronie’s disease: pharmacological treatments and limitations
Li, E. V., Esterquest, R., Pham, M. N., Panken, E. J., Amarasekera, C., Siebert, A., Bajic, P., & Levine, L. A. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1903873 · Cited by 24
Paulis, G., De Giorgio, G., & Paulis, L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415969 · Cited by 21
Metadata
- Authors
- Favilla, V., Russo, G. I., Privitera, S., Castelli, T., Madonia, M., La Vignera, S., Condorelli, R., Calogero, A. E., Farina, F. P., Cimino, S., & Morgia, G.
- Venue
- Andrologia
- Publisher
- Wiley
- Published
- 2013-10-11
- Volume
- 46
- Issue
- 8
- Pages
- 936-942
- ISSN
- 0303-4569 (ISSN-L)
- OpenAlex
- W1999109601
- Cited by
- 45
- References
- 5
- FWCI
- 2.98
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study. https://app.cochat.ai/papers/10.1111/and.12178
- The paper
- Favilla, V., Russo, G. I., Privitera, S., Castelli, T., Madonia, M., La Vignera, S., Condorelli, R., Calogero, A. E., Farina, F. P., Cimino, S., & Morgia, G. (2014). Combination of intralesional verapamil and oral antioxidants for Peyronie's disease: a prospective, randomised controlled study. Andrologia. https://doi.org/10.1111/and.12178
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.